Evidence map›Paper›PMID 40150600›Full record

ArticleChildren (Basel, Switzerland)2025

Advancing Pediatric Growth Assessment with Machine Learning: Overcoming Challenges in Early Diagnosis and Monitoring.

Mauro Rodriguez-Marin, Luis Gustavo Orozco-Alatorre

Abstract read
In one paragraph

Article in Children (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Mauro Rodriguez-MarinDepartament of Marketing and Analysis, Tecnologico de Monterrey Campus Guadalajara, Zapopan 45201, Mexico.ORCID 0000-0003-3003-8686
Luis Gustavo Orozco-AlatorreHospital Civil de Guadalajara "Dr. Juan I. Menchaca", Universidad de Guadalajara, Guadalajara 44100, Mexico.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPediatric growth assessment is crucial for early diagnosis and intervention in growth disorders. Traditional methods often lack accuracy and real-time decision-making capabilities This study explores the application of machine learning (ML), particularly logistic regression, to improve diagnostic precision and timeliness in pediatric growth assessment. Logistic regression is a reliable and easily interpretable model for detecting growth abnormalities in children. Unlike complex machine learning models, it offers parsimony in transparency, efficiency, and reproducibility, making it ideal for clinical settings where explainable, data-driven decisions are essential.

methodsA logistic regression model was developed using R to analyze biometric and demographic data from a cross-sectional dataset, including real-world data from public institucions. The study employed a bibliometric analysis to identify key trends and incorporated data preprocessing techniques such as cleaning, imputation, and feature selection to enhance model performance. Performance metrics, including accuracy, sensitivity, and the Receiver Operating Characteristic (ROC) curve, were utilized for evaluation.

resultsThe logistic regression model demonstrated an accuracy of 94.65% and a sensitivity of 91.03%, significantly improving the identification of growth anomalies compared to conventional assessment methods. The model's ROC curve showed an area under the curve (AUC) of 0.96, indicating excellent predictive capability. Findings highlight ML's potential in automating pediatric growth monitoring and supporting clinical decision-making, as it can be very simple and highly interpretable in clinical practice.

conclusionsML, particularly logistic regression, offers a promising tool for pediatric healthcare by enhancing diagnostic precision and operational efficiency. Despite these advancements, challenges remain regarding data quality, clinical integration, and privacy concerns. Future research should focus on expanding dataset diversity, improving model interpretability, and conducting external validation to facilitate broader clinical adoption.

Indexed as

Artificial Intelligence (AI)childrenhealthlogistic regressionmachine learning (ML)pediatric growth anomalies

Identifiers

PMID40150600
PMCPMC11941653

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.